Vinorelbine Tartrate and Cyclophosphamide in Combination With Bevacizumab or Temsirolimus in Treating Patients With Recurrent or Refractory Rhabdomyosarcoma

Conditions:   Adult Rhabdomyosarcoma;   Childhood Alveolar Rhabdomyosarcoma;   Childhood Pleomorphic Rhabdomyosarcoma;   Childhood Rhabdomyosarcoma With Mixed Embryonal and Alveolar Features;   Previously Treated Childhood Rhabdomyosarcoma;   Recurrent Adult Soft Tissue Sarcoma;   Recurrent Childhood RhabdomyosarcomaInterventions:   Biological: Bevacizumab;   Drug: Cyclophosphamide;   Other: Laboratory Biomarker Analysis;   Drug: Temsirolimus;   Drug: Vinorelbine TartrateSponsor:   National Cancer Institute (NCI)Active, not recruiting - verified January 2015
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials